Loading…

What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?

Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently,...

Full description

Saved in:
Bibliographic Details
Published in:PloS one 2013-02, Vol.8 (2), p.e55921-e55921
Main Authors: Bonnefond, Amélie, Saulnier, Pierre-Jean, Stathopoulou, Maria G, Grarup, Niels, Ndiaye, Ndeye Coumba, Roussel, Ronan, Nezhad, Mohsen Azimi, Dechaume, Aurélie, Lantieri, Olivier, Hercberg, Serge, Lauritzen, Torsten, Balkau, Beverley, El-Sayed Moustafa, Julia S, Hansen, Torben, Pedersen, Oluf, Froguel, Philippe, Charpentier, Guillaume, Marre, Michel, Hadjadj, Samy, Visvikis-Siest, Sophie
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723
cites cdi_FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723
container_end_page e55921
container_issue 2
container_start_page e55921
container_title PloS one
container_volume 8
creator Bonnefond, Amélie
Saulnier, Pierre-Jean
Stathopoulou, Maria G
Grarup, Niels
Ndiaye, Ndeye Coumba
Roussel, Ronan
Nezhad, Mohsen Azimi
Dechaume, Aurélie
Lantieri, Olivier
Hercberg, Serge
Lauritzen, Torsten
Balkau, Beverley
El-Sayed Moustafa, Julia S
Hansen, Torben
Pedersen, Oluf
Froguel, Philippe
Charpentier, Guillaume
Marre, Michel
Hadjadj, Samy
Visvikis-Siest, Sophie
description Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and rs10738760) explaining nearly half of the variance in circulating VEGF levels. Considering the putative contribution of VEGF to T2D and its complications, we aimed to assess the effect of these VEGF-related SNPs on the risk of T2D, nephropathy and retinopathy, as well as on variation in related traits.SNPs were genotyped in several case-control studies: French and Danish T2D studies (N(cases) = 6,920-N(controls) = 3,875 and N(cases) = 3,561-N(controls) = 2,623; respectively), two French studies one for diabetic nephropathy (N(cases) = 1,242-N(controls) = 860) and the other for diabetic retinopathy (N(cases) = 1,336-N(controls) = 1,231). The effects of each SNP on quantitative traits were analyzed in a French general population-based cohort (N = 4,760) and two French T2D studies (N = 3,480). SNP associations were assessed using logistic or linear regressions.In the French population, we found an association between the G-allele of rs6921438, shown to increase circulating VEGF levels, and increased T2D risk (OR = 1.15; P = 3.7×10(-5)). Furthermore, the same allele was associated with higher glycated hemoglobin levels (β = 0.02%; P = 9.2×10(-3)). However, these findings were not confirmed in the Danes. Conversely, the SNP rs10738760 was not associated with T2D in the French or Danish populations. Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients.In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy. The link between VEGF and T2D and its complications might be indirect and more complex than expected.
doi_str_mv 10.1371/journal.pone.0055921
format article
fullrecord <record><control><sourceid>gale_plos_</sourceid><recordid>TN_cdi_plos_journals_1330878789</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A478413883</galeid><doaj_id>oai_doaj_org_article_65d92f069f474f9ba018262a99f82b27</doaj_id><sourcerecordid>A478413883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723</originalsourceid><addsrcrecordid>eNqNk0tv1DAQxyMEomXhGyCwhIToYRc_Ej8uoFXVl1SpEo9ytJysk3XxxkvsLPTMF2fSTatu1QPyIdH49_-PPZ7JstcEzwgT5ONV6LvW-Nk6tHaGcVEoSp5k-0QxOuUUs6f3_veyFzFeAcQk58-zPcpyXFAm9rO_P5YmIRdRWlpUhTZ1ruyTCy0KNUq_A2psa5Or0MZ0zrQpos42vTfJtQ26PDo5Rt5urAd9QOl6bRFFC2dKmyyQLv5Epl0MeytXdWFjYgXaDhKt1t5VZkgUP7_MntXGR_tq_E6y78dH3w5Pp-cXJ2eH8_NpJShPU1PIXGFV0iIviSiIVJaLvKaVYpjTgsoil7w2nFTKCsNtDVFRUGFZSYpcUDbJ3m591z5EPdYvasIYlgKWAuJsSyyCudLrzq1Md62DcfomELpGmw6q4a3mxUJRSKHqHA6hSoOJpJwapWpJSyrA69OYrS9XdlFZqK3xO6a7O61b6iZsNCs4x0qCwcHWYPlAdjo_10MME4ElY2xDgP0wJuvCr97GpFcuVtZ709rQwx0p3E8KIQbbdw_QxysxUo2By7q2DnDGajDV81zInDAJqSfZ7BEK1sLCg0Nj1g7iO4KDHcHQcfZPakwfoz77-uX_2YvLXfb9PXZpjU_LGPxNJ8ddMN-C0I4xdra-qyzBepir22roYa70OFcge3P_Me9Et4PE_gFTpxuX</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1330878789</pqid></control><display><type>article</type><title>What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?</title><source>NCBI_PubMed Central(免费)</source><source>Publicly Available Content Database</source><creator>Bonnefond, Amélie ; Saulnier, Pierre-Jean ; Stathopoulou, Maria G ; Grarup, Niels ; Ndiaye, Ndeye Coumba ; Roussel, Ronan ; Nezhad, Mohsen Azimi ; Dechaume, Aurélie ; Lantieri, Olivier ; Hercberg, Serge ; Lauritzen, Torsten ; Balkau, Beverley ; El-Sayed Moustafa, Julia S ; Hansen, Torben ; Pedersen, Oluf ; Froguel, Philippe ; Charpentier, Guillaume ; Marre, Michel ; Hadjadj, Samy ; Visvikis-Siest, Sophie</creator><contributor>Buzzetti, Raffaella</contributor><creatorcontrib>Bonnefond, Amélie ; Saulnier, Pierre-Jean ; Stathopoulou, Maria G ; Grarup, Niels ; Ndiaye, Ndeye Coumba ; Roussel, Ronan ; Nezhad, Mohsen Azimi ; Dechaume, Aurélie ; Lantieri, Olivier ; Hercberg, Serge ; Lauritzen, Torsten ; Balkau, Beverley ; El-Sayed Moustafa, Julia S ; Hansen, Torben ; Pedersen, Oluf ; Froguel, Philippe ; Charpentier, Guillaume ; Marre, Michel ; Hadjadj, Samy ; Visvikis-Siest, Sophie ; Buzzetti, Raffaella</creatorcontrib><description>Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and rs10738760) explaining nearly half of the variance in circulating VEGF levels. Considering the putative contribution of VEGF to T2D and its complications, we aimed to assess the effect of these VEGF-related SNPs on the risk of T2D, nephropathy and retinopathy, as well as on variation in related traits.SNPs were genotyped in several case-control studies: French and Danish T2D studies (N(cases) = 6,920-N(controls) = 3,875 and N(cases) = 3,561-N(controls) = 2,623; respectively), two French studies one for diabetic nephropathy (N(cases) = 1,242-N(controls) = 860) and the other for diabetic retinopathy (N(cases) = 1,336-N(controls) = 1,231). The effects of each SNP on quantitative traits were analyzed in a French general population-based cohort (N = 4,760) and two French T2D studies (N = 3,480). SNP associations were assessed using logistic or linear regressions.In the French population, we found an association between the G-allele of rs6921438, shown to increase circulating VEGF levels, and increased T2D risk (OR = 1.15; P = 3.7×10(-5)). Furthermore, the same allele was associated with higher glycated hemoglobin levels (β = 0.02%; P = 9.2×10(-3)). However, these findings were not confirmed in the Danes. Conversely, the SNP rs10738760 was not associated with T2D in the French or Danish populations. Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients.In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy. The link between VEGF and T2D and its complications might be indirect and more complex than expected.</description><identifier>ISSN: 1932-6203</identifier><identifier>EISSN: 1932-6203</identifier><identifier>DOI: 10.1371/journal.pone.0055921</identifier><identifier>PMID: 23405237</identifier><language>eng</language><publisher>United States: Public Library of Science</publisher><subject>Alleles ; Angiogenesis ; Biology ; Case-Control Studies ; Chromosomes ; Complications ; Diabetes ; Diabetes Complications - blood ; Diabetes Complications - diagnosis ; Diabetes Complications - etiology ; Diabetes mellitus ; Diabetes Mellitus, Type 2 - blood ; Diabetes Mellitus, Type 2 - genetics ; Diabetic nephropathies ; Diabetic Nephropathies - blood ; Diabetic Nephropathies - diagnosis ; Diabetic Nephropathies - etiology ; Diabetic nephropathy ; Diabetic retinopathy ; Diabetic Retinopathy - blood ; Diabetic Retinopathy - diagnosis ; Diabetic Retinopathy - etiology ; Endocrinology ; Female ; Gene loci ; Genetic diversity ; Genetic Predisposition to Disease ; Genetic research ; Genetic variance ; Genetics ; Genome-wide association studies ; Genome-Wide Association Study ; Genomes ; Genomics ; Genotype ; Glycated Hemoglobin A - metabolism ; Glycosylated hemoglobin ; Health risks ; Health sciences ; Hemoglobin ; Hospitals ; Human genetics ; Humans ; Life Sciences ; Longitudinal Studies ; Low density lipoprotein receptors ; Male ; Medicine ; Metabolism ; Microvasculature ; Middle Aged ; Nephropathy ; Nutrition ; Permeability ; Polymerase Chain Reaction ; Polymorphism, Single Nucleotide - genetics ; Population (statistical) ; Population genetics ; Public health ; Regression analysis ; Retinopathy ; Risk ; Risk Factors ; Single nucleotide polymorphisms ; Single-nucleotide polymorphism ; Type 2 diabetes ; Variance ; Vascular endothelial growth factor ; Vascular Endothelial Growth Factor A - blood ; Vascular endothelial growth factor receptors</subject><ispartof>PloS one, 2013-02, Vol.8 (2), p.e55921-e55921</ispartof><rights>COPYRIGHT 2013 Public Library of Science</rights><rights>2013 Bonnefond et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>Distributed under a Creative Commons Attribution 4.0 International License</rights><rights>2013 Bonnefond et al 2013 Bonnefond et al</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723</citedby><cites>FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723</cites><orcidid>0000-0001-6124-5712 ; 0000-0002-3168-1350 ; 0000-0001-8104-8425 ; 0000-0001-9976-3005 ; 0000-0003-1862-4252 ; 0000-0003-2021-413X ; 0000-0001-8748-3831</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/1330878789/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/1330878789?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25751,27922,27923,37010,37011,44588,53789,53791,74896</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23405237$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink><backlink>$$Uhttps://hal.univ-lorraine.fr/hal-01708333$$DView record in HAL$$Hfree_for_read</backlink></links><search><contributor>Buzzetti, Raffaella</contributor><creatorcontrib>Bonnefond, Amélie</creatorcontrib><creatorcontrib>Saulnier, Pierre-Jean</creatorcontrib><creatorcontrib>Stathopoulou, Maria G</creatorcontrib><creatorcontrib>Grarup, Niels</creatorcontrib><creatorcontrib>Ndiaye, Ndeye Coumba</creatorcontrib><creatorcontrib>Roussel, Ronan</creatorcontrib><creatorcontrib>Nezhad, Mohsen Azimi</creatorcontrib><creatorcontrib>Dechaume, Aurélie</creatorcontrib><creatorcontrib>Lantieri, Olivier</creatorcontrib><creatorcontrib>Hercberg, Serge</creatorcontrib><creatorcontrib>Lauritzen, Torsten</creatorcontrib><creatorcontrib>Balkau, Beverley</creatorcontrib><creatorcontrib>El-Sayed Moustafa, Julia S</creatorcontrib><creatorcontrib>Hansen, Torben</creatorcontrib><creatorcontrib>Pedersen, Oluf</creatorcontrib><creatorcontrib>Froguel, Philippe</creatorcontrib><creatorcontrib>Charpentier, Guillaume</creatorcontrib><creatorcontrib>Marre, Michel</creatorcontrib><creatorcontrib>Hadjadj, Samy</creatorcontrib><creatorcontrib>Visvikis-Siest, Sophie</creatorcontrib><title>What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?</title><title>PloS one</title><addtitle>PLoS One</addtitle><description>Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and rs10738760) explaining nearly half of the variance in circulating VEGF levels. Considering the putative contribution of VEGF to T2D and its complications, we aimed to assess the effect of these VEGF-related SNPs on the risk of T2D, nephropathy and retinopathy, as well as on variation in related traits.SNPs were genotyped in several case-control studies: French and Danish T2D studies (N(cases) = 6,920-N(controls) = 3,875 and N(cases) = 3,561-N(controls) = 2,623; respectively), two French studies one for diabetic nephropathy (N(cases) = 1,242-N(controls) = 860) and the other for diabetic retinopathy (N(cases) = 1,336-N(controls) = 1,231). The effects of each SNP on quantitative traits were analyzed in a French general population-based cohort (N = 4,760) and two French T2D studies (N = 3,480). SNP associations were assessed using logistic or linear regressions.In the French population, we found an association between the G-allele of rs6921438, shown to increase circulating VEGF levels, and increased T2D risk (OR = 1.15; P = 3.7×10(-5)). Furthermore, the same allele was associated with higher glycated hemoglobin levels (β = 0.02%; P = 9.2×10(-3)). However, these findings were not confirmed in the Danes. Conversely, the SNP rs10738760 was not associated with T2D in the French or Danish populations. Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients.In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy. The link between VEGF and T2D and its complications might be indirect and more complex than expected.</description><subject>Alleles</subject><subject>Angiogenesis</subject><subject>Biology</subject><subject>Case-Control Studies</subject><subject>Chromosomes</subject><subject>Complications</subject><subject>Diabetes</subject><subject>Diabetes Complications - blood</subject><subject>Diabetes Complications - diagnosis</subject><subject>Diabetes Complications - etiology</subject><subject>Diabetes mellitus</subject><subject>Diabetes Mellitus, Type 2 - blood</subject><subject>Diabetes Mellitus, Type 2 - genetics</subject><subject>Diabetic nephropathies</subject><subject>Diabetic Nephropathies - blood</subject><subject>Diabetic Nephropathies - diagnosis</subject><subject>Diabetic Nephropathies - etiology</subject><subject>Diabetic nephropathy</subject><subject>Diabetic retinopathy</subject><subject>Diabetic Retinopathy - blood</subject><subject>Diabetic Retinopathy - diagnosis</subject><subject>Diabetic Retinopathy - etiology</subject><subject>Endocrinology</subject><subject>Female</subject><subject>Gene loci</subject><subject>Genetic diversity</subject><subject>Genetic Predisposition to Disease</subject><subject>Genetic research</subject><subject>Genetic variance</subject><subject>Genetics</subject><subject>Genome-wide association studies</subject><subject>Genome-Wide Association Study</subject><subject>Genomes</subject><subject>Genomics</subject><subject>Genotype</subject><subject>Glycated Hemoglobin A - metabolism</subject><subject>Glycosylated hemoglobin</subject><subject>Health risks</subject><subject>Health sciences</subject><subject>Hemoglobin</subject><subject>Hospitals</subject><subject>Human genetics</subject><subject>Humans</subject><subject>Life Sciences</subject><subject>Longitudinal Studies</subject><subject>Low density lipoprotein receptors</subject><subject>Male</subject><subject>Medicine</subject><subject>Metabolism</subject><subject>Microvasculature</subject><subject>Middle Aged</subject><subject>Nephropathy</subject><subject>Nutrition</subject><subject>Permeability</subject><subject>Polymerase Chain Reaction</subject><subject>Polymorphism, Single Nucleotide - genetics</subject><subject>Population (statistical)</subject><subject>Population genetics</subject><subject>Public health</subject><subject>Regression analysis</subject><subject>Retinopathy</subject><subject>Risk</subject><subject>Risk Factors</subject><subject>Single nucleotide polymorphisms</subject><subject>Single-nucleotide polymorphism</subject><subject>Type 2 diabetes</subject><subject>Variance</subject><subject>Vascular endothelial growth factor</subject><subject>Vascular Endothelial Growth Factor A - blood</subject><subject>Vascular endothelial growth factor receptors</subject><issn>1932-6203</issn><issn>1932-6203</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNqNk0tv1DAQxyMEomXhGyCwhIToYRc_Ej8uoFXVl1SpEo9ytJysk3XxxkvsLPTMF2fSTatu1QPyIdH49_-PPZ7JstcEzwgT5ONV6LvW-Nk6tHaGcVEoSp5k-0QxOuUUs6f3_veyFzFeAcQk58-zPcpyXFAm9rO_P5YmIRdRWlpUhTZ1ruyTCy0KNUq_A2psa5Or0MZ0zrQpos42vTfJtQ26PDo5Rt5urAd9QOl6bRFFC2dKmyyQLv5Epl0MeytXdWFjYgXaDhKt1t5VZkgUP7_MntXGR_tq_E6y78dH3w5Pp-cXJ2eH8_NpJShPU1PIXGFV0iIviSiIVJaLvKaVYpjTgsoil7w2nFTKCsNtDVFRUGFZSYpcUDbJ3m591z5EPdYvasIYlgKWAuJsSyyCudLrzq1Md62DcfomELpGmw6q4a3mxUJRSKHqHA6hSoOJpJwapWpJSyrA69OYrS9XdlFZqK3xO6a7O61b6iZsNCs4x0qCwcHWYPlAdjo_10MME4ElY2xDgP0wJuvCr97GpFcuVtZ709rQwx0p3E8KIQbbdw_QxysxUo2By7q2DnDGajDV81zInDAJqSfZ7BEK1sLCg0Nj1g7iO4KDHcHQcfZPakwfoz77-uX_2YvLXfb9PXZpjU_LGPxNJ8ddMN-C0I4xdra-qyzBepir22roYa70OFcge3P_Me9Et4PE_gFTpxuX</recordid><startdate>20130206</startdate><enddate>20130206</enddate><creator>Bonnefond, Amélie</creator><creator>Saulnier, Pierre-Jean</creator><creator>Stathopoulou, Maria G</creator><creator>Grarup, Niels</creator><creator>Ndiaye, Ndeye Coumba</creator><creator>Roussel, Ronan</creator><creator>Nezhad, Mohsen Azimi</creator><creator>Dechaume, Aurélie</creator><creator>Lantieri, Olivier</creator><creator>Hercberg, Serge</creator><creator>Lauritzen, Torsten</creator><creator>Balkau, Beverley</creator><creator>El-Sayed Moustafa, Julia S</creator><creator>Hansen, Torben</creator><creator>Pedersen, Oluf</creator><creator>Froguel, Philippe</creator><creator>Charpentier, Guillaume</creator><creator>Marre, Michel</creator><creator>Hadjadj, Samy</creator><creator>Visvikis-Siest, Sophie</creator><general>Public Library of Science</general><general>Public Library of Science (PLoS)</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IOV</scope><scope>ISR</scope><scope>3V.</scope><scope>7QG</scope><scope>7QL</scope><scope>7QO</scope><scope>7RV</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TG</scope><scope>7TM</scope><scope>7U9</scope><scope>7X2</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABJCF</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>ATCPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>D1I</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>H94</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB.</scope><scope>KB0</scope><scope>KL.</scope><scope>L6V</scope><scope>LK8</scope><scope>M0K</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>M7P</scope><scope>M7S</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PATMY</scope><scope>PDBOC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PTHSS</scope><scope>PYCSY</scope><scope>RC3</scope><scope>7X8</scope><scope>1XC</scope><scope>VOOES</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0001-6124-5712</orcidid><orcidid>https://orcid.org/0000-0002-3168-1350</orcidid><orcidid>https://orcid.org/0000-0001-8104-8425</orcidid><orcidid>https://orcid.org/0000-0001-9976-3005</orcidid><orcidid>https://orcid.org/0000-0003-1862-4252</orcidid><orcidid>https://orcid.org/0000-0003-2021-413X</orcidid><orcidid>https://orcid.org/0000-0001-8748-3831</orcidid></search><sort><creationdate>20130206</creationdate><title>What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?</title><author>Bonnefond, Amélie ; Saulnier, Pierre-Jean ; Stathopoulou, Maria G ; Grarup, Niels ; Ndiaye, Ndeye Coumba ; Roussel, Ronan ; Nezhad, Mohsen Azimi ; Dechaume, Aurélie ; Lantieri, Olivier ; Hercberg, Serge ; Lauritzen, Torsten ; Balkau, Beverley ; El-Sayed Moustafa, Julia S ; Hansen, Torben ; Pedersen, Oluf ; Froguel, Philippe ; Charpentier, Guillaume ; Marre, Michel ; Hadjadj, Samy ; Visvikis-Siest, Sophie</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Alleles</topic><topic>Angiogenesis</topic><topic>Biology</topic><topic>Case-Control Studies</topic><topic>Chromosomes</topic><topic>Complications</topic><topic>Diabetes</topic><topic>Diabetes Complications - blood</topic><topic>Diabetes Complications - diagnosis</topic><topic>Diabetes Complications - etiology</topic><topic>Diabetes mellitus</topic><topic>Diabetes Mellitus, Type 2 - blood</topic><topic>Diabetes Mellitus, Type 2 - genetics</topic><topic>Diabetic nephropathies</topic><topic>Diabetic Nephropathies - blood</topic><topic>Diabetic Nephropathies - diagnosis</topic><topic>Diabetic Nephropathies - etiology</topic><topic>Diabetic nephropathy</topic><topic>Diabetic retinopathy</topic><topic>Diabetic Retinopathy - blood</topic><topic>Diabetic Retinopathy - diagnosis</topic><topic>Diabetic Retinopathy - etiology</topic><topic>Endocrinology</topic><topic>Female</topic><topic>Gene loci</topic><topic>Genetic diversity</topic><topic>Genetic Predisposition to Disease</topic><topic>Genetic research</topic><topic>Genetic variance</topic><topic>Genetics</topic><topic>Genome-wide association studies</topic><topic>Genome-Wide Association Study</topic><topic>Genomes</topic><topic>Genomics</topic><topic>Genotype</topic><topic>Glycated Hemoglobin A - metabolism</topic><topic>Glycosylated hemoglobin</topic><topic>Health risks</topic><topic>Health sciences</topic><topic>Hemoglobin</topic><topic>Hospitals</topic><topic>Human genetics</topic><topic>Humans</topic><topic>Life Sciences</topic><topic>Longitudinal Studies</topic><topic>Low density lipoprotein receptors</topic><topic>Male</topic><topic>Medicine</topic><topic>Metabolism</topic><topic>Microvasculature</topic><topic>Middle Aged</topic><topic>Nephropathy</topic><topic>Nutrition</topic><topic>Permeability</topic><topic>Polymerase Chain Reaction</topic><topic>Polymorphism, Single Nucleotide - genetics</topic><topic>Population (statistical)</topic><topic>Population genetics</topic><topic>Public health</topic><topic>Regression analysis</topic><topic>Retinopathy</topic><topic>Risk</topic><topic>Risk Factors</topic><topic>Single nucleotide polymorphisms</topic><topic>Single-nucleotide polymorphism</topic><topic>Type 2 diabetes</topic><topic>Variance</topic><topic>Vascular endothelial growth factor</topic><topic>Vascular Endothelial Growth Factor A - blood</topic><topic>Vascular endothelial growth factor receptors</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Bonnefond, Amélie</creatorcontrib><creatorcontrib>Saulnier, Pierre-Jean</creatorcontrib><creatorcontrib>Stathopoulou, Maria G</creatorcontrib><creatorcontrib>Grarup, Niels</creatorcontrib><creatorcontrib>Ndiaye, Ndeye Coumba</creatorcontrib><creatorcontrib>Roussel, Ronan</creatorcontrib><creatorcontrib>Nezhad, Mohsen Azimi</creatorcontrib><creatorcontrib>Dechaume, Aurélie</creatorcontrib><creatorcontrib>Lantieri, Olivier</creatorcontrib><creatorcontrib>Hercberg, Serge</creatorcontrib><creatorcontrib>Lauritzen, Torsten</creatorcontrib><creatorcontrib>Balkau, Beverley</creatorcontrib><creatorcontrib>El-Sayed Moustafa, Julia S</creatorcontrib><creatorcontrib>Hansen, Torben</creatorcontrib><creatorcontrib>Pedersen, Oluf</creatorcontrib><creatorcontrib>Froguel, Philippe</creatorcontrib><creatorcontrib>Charpentier, Guillaume</creatorcontrib><creatorcontrib>Marre, Michel</creatorcontrib><creatorcontrib>Hadjadj, Samy</creatorcontrib><creatorcontrib>Visvikis-Siest, Sophie</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Gale In Context: Opposing Viewpoints</collection><collection>Gale In Context: Science</collection><collection>ProQuest Central (Corporate)</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Biotechnology Research Abstracts</collection><collection>ProQuest Nursing &amp; Allied Health Database</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Meteorological &amp; Geoastrophysical Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Agricultural Science Collection</collection><collection>ProQuest_Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>ProQuest Public Health Database</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Materials Science &amp; Engineering Collection</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>Agricultural &amp; Environmental Science Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Materials Science Collection</collection><collection>ProQuest Central</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Materials Science Database</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>Meteorological &amp; Geoastrophysical Abstracts - Academic</collection><collection>ProQuest Engineering Collection</collection><collection>Biological Sciences</collection><collection>Agriculture Science Database</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biological Science Database</collection><collection>Engineering Database</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Environmental Science Database</collection><collection>Materials Science Collection</collection><collection>Publicly Available Content Database</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Engineering Collection</collection><collection>Environmental Science Collection</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>Hyper Article en Ligne (HAL)</collection><collection>Hyper Article en Ligne (HAL) (Open Access)</collection><collection>PubMed Central (Full Participant titles)</collection><collection>DOAJ Directory of Open Access Journals</collection><jtitle>PloS one</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Bonnefond, Amélie</au><au>Saulnier, Pierre-Jean</au><au>Stathopoulou, Maria G</au><au>Grarup, Niels</au><au>Ndiaye, Ndeye Coumba</au><au>Roussel, Ronan</au><au>Nezhad, Mohsen Azimi</au><au>Dechaume, Aurélie</au><au>Lantieri, Olivier</au><au>Hercberg, Serge</au><au>Lauritzen, Torsten</au><au>Balkau, Beverley</au><au>El-Sayed Moustafa, Julia S</au><au>Hansen, Torben</au><au>Pedersen, Oluf</au><au>Froguel, Philippe</au><au>Charpentier, Guillaume</au><au>Marre, Michel</au><au>Hadjadj, Samy</au><au>Visvikis-Siest, Sophie</au><au>Buzzetti, Raffaella</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?</atitle><jtitle>PloS one</jtitle><addtitle>PLoS One</addtitle><date>2013-02-06</date><risdate>2013</risdate><volume>8</volume><issue>2</issue><spage>e55921</spage><epage>e55921</epage><pages>e55921-e55921</pages><issn>1932-6203</issn><eissn>1932-6203</eissn><abstract>Vascular endothelial growth factor (VEGF) is a key chemokine involved in tissue growth and organ repair processes, particularly angiogenesis. Elevated circulating VEGF levels are believed to play a role in type 2 diabetes (T2D) microvascular complications, especially diabetic retinopathy. Recently, a genome-wide association study identified two common single nucleotide polymorphisms (SNPs; rs6921438 and rs10738760) explaining nearly half of the variance in circulating VEGF levels. Considering the putative contribution of VEGF to T2D and its complications, we aimed to assess the effect of these VEGF-related SNPs on the risk of T2D, nephropathy and retinopathy, as well as on variation in related traits.SNPs were genotyped in several case-control studies: French and Danish T2D studies (N(cases) = 6,920-N(controls) = 3,875 and N(cases) = 3,561-N(controls) = 2,623; respectively), two French studies one for diabetic nephropathy (N(cases) = 1,242-N(controls) = 860) and the other for diabetic retinopathy (N(cases) = 1,336-N(controls) = 1,231). The effects of each SNP on quantitative traits were analyzed in a French general population-based cohort (N = 4,760) and two French T2D studies (N = 3,480). SNP associations were assessed using logistic or linear regressions.In the French population, we found an association between the G-allele of rs6921438, shown to increase circulating VEGF levels, and increased T2D risk (OR = 1.15; P = 3.7×10(-5)). Furthermore, the same allele was associated with higher glycated hemoglobin levels (β = 0.02%; P = 9.2×10(-3)). However, these findings were not confirmed in the Danes. Conversely, the SNP rs10738760 was not associated with T2D in the French or Danish populations. Despite having adequate statistical power, we did not find any significant effects of rs6921438 or rs10738760 on diabetic microvascular complications or the variation in related traits in T2D patients.In spite of their impact on the variance in circulating VEGF, we did not find any association between SNPs rs6921438 and rs10738760, and the risk of T2D, diabetic nephropathy or retinopathy. The link between VEGF and T2D and its complications might be indirect and more complex than expected.</abstract><cop>United States</cop><pub>Public Library of Science</pub><pmid>23405237</pmid><doi>10.1371/journal.pone.0055921</doi><tpages>e55921</tpages><orcidid>https://orcid.org/0000-0001-6124-5712</orcidid><orcidid>https://orcid.org/0000-0002-3168-1350</orcidid><orcidid>https://orcid.org/0000-0001-8104-8425</orcidid><orcidid>https://orcid.org/0000-0001-9976-3005</orcidid><orcidid>https://orcid.org/0000-0003-1862-4252</orcidid><orcidid>https://orcid.org/0000-0003-2021-413X</orcidid><orcidid>https://orcid.org/0000-0001-8748-3831</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1932-6203
ispartof PloS one, 2013-02, Vol.8 (2), p.e55921-e55921
issn 1932-6203
1932-6203
language eng
recordid cdi_plos_journals_1330878789
source NCBI_PubMed Central(免费); Publicly Available Content Database
subjects Alleles
Angiogenesis
Biology
Case-Control Studies
Chromosomes
Complications
Diabetes
Diabetes Complications - blood
Diabetes Complications - diagnosis
Diabetes Complications - etiology
Diabetes mellitus
Diabetes Mellitus, Type 2 - blood
Diabetes Mellitus, Type 2 - genetics
Diabetic nephropathies
Diabetic Nephropathies - blood
Diabetic Nephropathies - diagnosis
Diabetic Nephropathies - etiology
Diabetic nephropathy
Diabetic retinopathy
Diabetic Retinopathy - blood
Diabetic Retinopathy - diagnosis
Diabetic Retinopathy - etiology
Endocrinology
Female
Gene loci
Genetic diversity
Genetic Predisposition to Disease
Genetic research
Genetic variance
Genetics
Genome-wide association studies
Genome-Wide Association Study
Genomes
Genomics
Genotype
Glycated Hemoglobin A - metabolism
Glycosylated hemoglobin
Health risks
Health sciences
Hemoglobin
Hospitals
Human genetics
Humans
Life Sciences
Longitudinal Studies
Low density lipoprotein receptors
Male
Medicine
Metabolism
Microvasculature
Middle Aged
Nephropathy
Nutrition
Permeability
Polymerase Chain Reaction
Polymorphism, Single Nucleotide - genetics
Population (statistical)
Population genetics
Public health
Regression analysis
Retinopathy
Risk
Risk Factors
Single nucleotide polymorphisms
Single-nucleotide polymorphism
Type 2 diabetes
Variance
Vascular endothelial growth factor
Vascular Endothelial Growth Factor A - blood
Vascular endothelial growth factor receptors
title What is the contribution of two genetic variants regulating VEGF levels to type 2 diabetes risk and to microvascular complications?
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T08%3A24%3A39IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_plos_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=What%20is%20the%20contribution%20of%20two%20genetic%20variants%20regulating%20VEGF%20levels%20to%20type%202%20diabetes%20risk%20and%20to%20microvascular%20complications?&rft.jtitle=PloS%20one&rft.au=Bonnefond,%20Am%C3%A9lie&rft.date=2013-02-06&rft.volume=8&rft.issue=2&rft.spage=e55921&rft.epage=e55921&rft.pages=e55921-e55921&rft.issn=1932-6203&rft.eissn=1932-6203&rft_id=info:doi/10.1371/journal.pone.0055921&rft_dat=%3Cgale_plos_%3EA478413883%3C/gale_plos_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c726t-a584909b254b175189e674f2c930625285486fa61c9e7a6ef0627527e3b154723%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1330878789&rft_id=info:pmid/23405237&rft_galeid=A478413883&rfr_iscdi=true